BVT Aktienanleihe AMD 28.03.2025/ DE000VD2UAF2 /
2024-06-24 10:23:37 AM | Chg.+0.060 | Bid11:08:35 AM | Ask11:08:35 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
95.610EUR | +0.06% | 95.580 Bid Size: 50,000 |
95.680 Ask Size: 50,000 |
ADVANCED MIC.DEV. D... | 160.00 - | 2025-03-28 | Call |
GlobeNewswire
06-19
AMD to Power AI-Based Smart Parking Solution for Sun Singapore, the Country’s Largest Provider of Sm...
GlobeNewswire
06-18
4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population E...
GlobeNewswire
06-17
D&H’s June 18 Hershey THREAD Technology Conference to Deliver AI-Readiness & Training
GlobeNewswire
06-14
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$1...
GlobeNewswire
06-13
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Stu...
GlobeNewswire
06-13
Global High-Performance Computing Servers Market Size Projected to Reach $26 Billion By 2032
GlobeNewswire
06-12
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at t...
GlobeNewswire
06-12
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire
06-12
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately...
GlobeNewswire
06-11
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire
06-10
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire
06-08
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...